|
|
|
Insider
Information: |
Makhzoumi Mohamad |
Relationship: |
|
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
16,083 |
|
Indirect Shares
|
68,130,184 |
|
|
Direct
Value |
$200,625 |
|
|
Indirect Value
|
$216,417,739 |
|
|
Total
Shares |
68,146,267 |
|
|
Total
Value |
$216,618,364 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
2
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
2
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
23.7%
|
-32.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
2022-10-19 |
559 |
2022-10-19 |
354 |
Premium* |
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
Premium* |
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2022-04-11 |
948,948 |
Premium* |
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2023-06-13 |
11,348 |
Premium* |
|
Ardelyx Inc |
ARDX |
10% Owner |
2019-12-09 |
0 |
2019-12-09 |
6,564,372 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
0 |
2020-07-14 |
2,902,115 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
2,437,689 |
Premium* |
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2021-12-22 |
2,563,257 |
Premium* |
|
Eargo, Inc. |
EAR |
10% Owner |
2021-05-25 |
0 |
2021-05-24 |
0 |
Premium* |
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
2021-06-08 |
1,273 |
2021-06-08 |
806 |
Premium* |
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2023-07-17 |
24,471,264 |
Premium* |
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
Bright Health Group Inc. |
BHG |
|
2024-05-12 |
5,943 |
2024-05-12 |
2,280,552 |
Premium* |
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
Robinhood Markets, Inc. |
HOOD |
Director |
2022-05-02 |
6,371 |
2022-05-03 |
0 |
Premium* |
|
Ionq Ord Shs |
IONQ |
10% Owner |
2022-11-16 |
1,654 |
2022-11-16 |
1,047 |
Premium* |
|
Arcellx, Inc. |
ACLX |
10% Owner |
2022-12-20 |
283 |
2022-12-21 |
0 |
Premium* |
|
Korro Bio |
KRRO |
|
|
0 |
2024-04-22 |
1,090,793 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
97 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2019-04-08 |
4 |
B |
$1.14 |
$4,956,523 |
I/I |
4,347,827 |
25,243,865 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2020-06-19 |
4 |
B |
$5.25 |
$7,499,998 |
I/I |
1,428,571 |
3,952,958 |
1.5 |
% |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
559 |
559 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
4,012,605 |
354 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,965,208) |
0 |
0 |
- |
|
BHG |
Bright Health Group Inc. |
Director |
|
2021-06-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
46,859,421 |
|
- |
|
BHG |
Bright Health Group Inc. |
Director |
|
2021-06-28 |
4 |
B |
$18.00 |
$34,999,992 |
I/I |
1,944,444 |
23,983,073 |
2.25 |
% |
|
BHG |
Bright Health Group Inc. |
Director |
|
2021-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
133,640,415 |
22,288,629 |
0 |
- |
|
BHG |
Bright Health Group Inc. |
Director |
|
2023-05-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
95,109 |
95,109 |
0 |
- |
|
BHG |
Bright Health Group Inc. |
|
|
2024-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,755 |
5,943 |
0 |
- |
|
DM |
Desktop Metal Ord Shs Cla... |
10% Owner |
|
2020-12-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
28,398,927 |
|
- |
|
DM |
Desktop Metal Ord Shs Cla... |
10% Owner |
|
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,273 |
1,273 |
0 |
- |
|
DM |
Desktop Metal Ord Shs Cla... |
10% Owner |
|
2021-06-08 |
4 |
A |
$0.00 |
$0 |
I/I |
135,806 |
806 |
0 |
- |
|
DM |
Desktop Metal Ord Shs Cla... |
10% Owner |
|
2021-06-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(9,135,000) |
0 |
0 |
- |
|
EAR |
Eargo, Inc. |
10% Owner |
|
2020-10-20 |
4 |
B |
$18.00 |
$5,599,998 |
I/I |
311,111 |
6,520,017 |
1.5 |
- |
|
EAR |
Eargo, Inc. |
10% Owner |
|
2020-10-20 |
4 |
A |
$0.00 |
$0 |
I/I |
6,208,906 |
6,208,906 |
0 |
- |
|
EAR |
Eargo, Inc. |
10% Owner |
|
2021-05-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
0 |
- |
|
EAR |
Eargo, Inc. |
10% Owner |
|
2021-05-24 |
4 |
A |
$0.00 |
$0 |
I/I |
30,000 |
30,000 |
0 |
- |
|
EAR |
Eargo, Inc. |
10% Owner |
|
2021-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
283 |
283 |
0 |
- |
|
EAR |
Eargo, Inc. |
10% Owner |
|
2021-05-25 |
4 |
S |
$32.41 |
$9,172 |
D/D |
(283) |
0 |
0 |
- |
|
GLUE |
Monte Rosa Therapeutics, ... |
10% Owner |
|
2021-06-28 |
4 |
B |
$19.00 |
$19,950,000 |
I/I |
1,050,000 |
7,692,298 |
1.5 |
- |
|
GLUE |
Monte Rosa Therapeutics, ... |
10% Owner |
|
2021-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
6,642,298 |
6,642,298 |
0 |
- |
|
GNCA |
Genocea Biosciences, Inc. |
10% Owner |
|
2019-02-14 |
4 |
B |
$0.47 |
$4,688,619 |
I/I |
9,948,269 |
34,948,269 |
1.5 |
- |
|
GNCA |
Genocea Biosciences, Inc. |
10% Owner |
|
2019-06-24 |
4 |
B |
$3.50 |
$9,999,997 |
I/I |
2,857,142 |
7,225,676 |
1.5 |
- |
|
GNCA |
Genocea Biosciences, Inc. |
10% Owner |
|
2020-07-24 |
4 |
B |
$2.25 |
$7,090,335 |
I/I |
3,151,260 |
10,376,936 |
1.5 |
- |
|
97 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|